Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,11S,14S,20S,23S,26S,29S,32S,35S)-35,39-diamino-14-(2-amino-2-oxoethyl)-2-(4-aminobutyl)-5-benzyl-20-sec-butyl-23-(3-guanidinopropyl)-8,29-bis(4-hydroxybenzyl)-11-(hydroxymethyl)-26,32-dimethyl-4,7,10,13,16,19,22,25,28,31,34-undecaoxo-3,6,9,12,15,18,21,24,27,30,33-undecaazanonatriacontan-1-oic acid
ID: ALA4760133
PubChem CID: 162658308
Max Phase: Preclinical
Molecular Formula: C66H100N18O17
Molecular Weight: 1417.64
Molecule Type: Unknown
Associated Items: